文献速递精神分裂症与精神病性障碍心境障碍会诊联络精神医学

青少年炎症轨迹与成年期精神及心血管代谢障碍风险

Trajectories of Inflammation in Youth and Risk of Mental and Cardiometabolic Disorders in Adulthood.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

基于ALSPAC纵向队列6556名参与者,采用潜类别增长分析按9、15、17岁C反应蛋白水平识别三种炎症轨迹,并以 logistic 回归分析其与24岁时精神障碍及HOMA2评分的关联。早发峰值组相比持续低CRP组,精神病性障碍、重度抑郁风险及HOMA2评分更高;晚发峰值组与24岁时各项结局无关。作者认为生命早期低度持续炎症可能是精神-躯体共病的重要共同因素。

要点

  • 早发峰值组精神病性障碍OR 4.60(95%CI 1.81-11.70,P=.008),重度抑郁OR 4.37(95%CI 1.64-11.63,P=.02)。
  • 早发峰值组HOMA2评分较持续低CRP组升高(β=0.05;95%CI 0.01-0.62,P=.04)。
  • 晚发峰值组与24岁时任何结局均无关联。

核心结论

  • 儿童中期达峰的低度全身炎症与成年早期特定精神障碍及心血管代谢障碍相关。
  • 作者认为生命早期低度持续炎症可能是精神-躯体共病的重要共同因素,或与未来患者分层和风险画像工作相关。

研究设计与样本

  • 基于英国Avon亲子纵向研究(ALSPAC)的纵向队列研究,采用潜类别增长分析识别炎症轨迹并以logistic回归分析关联。
  • 共纳入6556名参与者,其中女性3303名(50.4%);暴露为9、15、17岁时的C反应蛋白水平。
  • 数据分析时间为2023年5月1日至2024年3月30日。

主要发现

  • 识别出三类炎症轨迹:持续低CRP组(参照组,n=6109)、持续升高且9岁达峰的早发峰值组(n=197)、持续升高且17岁达峰的晚发峰值组(n=250)。
  • 早发峰值组相较持续低CRP组,精神病性障碍风险更高(OR 4.60;95%CI 1.81-11.70;P=.008)。
  • 早发峰值组相较持续低CRP组,重度抑郁风险更高(OR 4.37;95%CI 1.64-11.63;P=.02)。
  • 早发峰值组相较持续低CRP组,HOMA2评分更高(β=0.05;95%CI 0.01-0.62,P=.04)。
  • 晚发峰值组与24岁时任何结局均无关联。

临床怎么用

  • 作者认为生命早期低度持续炎症可能是精神-躯体共病的重要共同因素,或与未来患者分层和风险画像工作相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Research suggests that low-grade, nonresolving inflammation may predate adult mental and physical illness. However, evidence to date is largely cross-sectional or focuses on single disorder outcomes. OBJECTIVES: To examine trajectories of inflammation as measured by C-reactive protein (CRP) levels in a large sample of children and adolescents, and to explore associations between different identified trajectories and mental and related cardiometabolic health outcomes in early adulthood. DESIGN, SETTING, AND PARTICIPANTS: In a longitudinal cohort study using data from the large UK-based Avon Longitudinal Study of Parents and Children (ALSPAC), latent class growth analysis (LCGA) was used to explore different trajectories of inflammation, with logistic regression exploring association with mental and physical health outcomes. Participants with measurable CRP data and associated mental and cardiometabolic health outcomes recorded were included in the analysis. Data analysis was performed from May 1, 2023, to March 30, 2024. EXPOSURES: Inflammation was assessed via CRP levels at ages 9, 15, and 17 years. LCGA was used to identify different trajectories of inflammation. MAIN OUTCOMES AND MEASURES: Outcomes assessed at age 24 years included psychotic disorders, depressive disorders, anxiety disorders, hypomania, and, as a measure of insulin resistance, Homeostasis Model Assessment (HOMA2) score. RESULTS: A total of 6556 participants (3303 [50.4%] female) were included. Three classes of inflammation were identified: persistently low CRP levels (reference class, n = 6109); persistently raised CRP levels, peaking at age 9 years (early peak, n = 197); and persistently raised CRP levels, peaking at age 17 years (late peak, n = 250). Participants in the early peak group were associated with a higher risk of psychotic disorder (odds ratio [OR], 4.60; 95% CI, 1.81-11.70; P = .008), a higher risk of severe depression (OR, 4.37; 95% CI, 1.64-11.63; P = .02), and higher HOMA2 scores (β = 0.05; 95% CI, 0.01-0.62, P = .04) compared with participants with persistently low CRP. The late peak group was not associated with any outcomes at age 24 years. CONCLUSIONS AND RELEVANCE: Low-grade systemic inflammation peaking in midchildhood was associated with specific mental and cardiometabolic disorders in young adulthood. These findings suggest that low-grade persistent inflammation in early life may be an important shared common factor for mental-physical comorbidity and so could be relevant to future efforts of patient stratification and risk profiling.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Palmer ER, Morales-Muñoz I, Perry BI, et al. Trajectories of Inflammation in Youth and Risk of Mental and Cardiometabolic Disorders in Adulthood. JAMA Psychiatry. 2024. PMID: 39167392. doi:10.1001/jamapsychiatry.2024.2193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。